CLINICAL_TRIALS
trial_result
· 2020-08-17
Clinical Trial Update: Preterm Erythropoietin Neuroprotection Trial (PENUT Trial) [Phase 3]
Summary
Phase 3 trial update for preterm erythropoietin neuroprotection (PENUT) in extremely premature infants; study completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Washington | Conditions: Extreme Prematurity | Phase 3 | Status: COMPLETED | Results posted: 2020-08-17